Healthcare & Life Sciences
Ypsilon Therapeutics
About
Ypsilon Therapeutics develops next-generation cancer therapies including T-cell receptor mimic antibodies and bispecific T-cell engagers targeting solid tumors such as triple-negative breast cancer and non-small-cell lung cancer while sparing healthy tissue.
Explore Ypsilon Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.